87 completed, 22 unknown, 21 recruiting, 19 terminated. 64 Not applicable, 46 Phase 2, 22 Phase 1, 8 Phase 3, 4 Phase 4.
Follow Breast Neoplasm: new trials by email Literature Review of Breast Neoplasm trials Research Report on Breast Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Molecular Breast Imaging (MBI)-Guided Biopsy Molecular Breast Imaging, MBI-guided biopsy - Breast Cancer Detection, Breast Neoplasm | Not applicable | Not yet recruiting | Smart Breast Corp. | 250 | 2027-06-01 | 2025-08-11 |
| Evaluating an AI-Based Mobile Application for Chemotherapy Support in Breast Cancer Patients AI-Based Mobile Application for Personalized Chemotherapy Support, Usual Care - Breast Cancer, Breast Neoplasm | Not applicable | Recruiting | Dena h. Al-Tameemi | 130 | 2026-06-01 | 2026-06-12 |
| Trial to Evaluate the Impact of Various Pragmatic Interventions to Increase Mammography Uptake Among Defaulted Repeat Screeners in Singapore Arm 2: One mailed reminder, Arm 3: Two mailed reminders, Arm 4: Mailed reminder with prescheduled appointment - Mammogram Uptake, Breast Cancer | Not applicable | Enrolling by invitation | National University Hospital, Singapore | 12750 | 2026-03-09 | 2026-06-16 |
| Surviving Daily Life Mobile Daily Diary - Stress, Cognitive Change | Terminated | Thomas Jefferson University | 17 | 2025-10-02 | 2026-10-28 | |
| Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon Satisfaction HydroMARK Plus Clip - Breast Neoplasm | Not applicable | Recruiting | University of Alabama at Birmingham | 150 | 2025-08-05 | 2026-09-25 |
| CRYoablation for Small Tumors As Local Treatment - SIX Trial cryoablation, Breast Surgery (Lumpectomy or Mastectomy) - Breast Cancer, Breast Neoplasm | Phase 3 | Recruiting | Hospital do Coracao | 750 | 2025-03-01 | 2025-06-26 |
| Health Economic Evaluation of an Adapted Physical Activity Program for Women With Breast Cancer APA Program, Recommendations for physical activity - Breast Neoplasm | Not applicable | Recruiting | University Hospital, Toulouse | 866 | 2024-12-23 | 2025-12-31 |
| A Prospective Study to Develop and Clinically Validate an in Vitro Diagnostic Medical Device That Uses Blood to Classify Patients at High Risk for Breast Cancer ExoPred - Breast Neoplasm | Recruiting | EXoPERT | 330 | 2024-10-16 | 2026-09-10 | |
| KNUCH CadAI-B-1(KCB-1) CadAI-B - Breast Neoplasm, Female | Not applicable | Unknown | JeeYeon Lee | 100 | 2024-09-15 | 2024-10-02 |
| Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy Tart Cherry Juice - Breast Cancer, Breast Cancer Stage I | Phase 2 | Recruiting | University of California, Davis | 86 | 2024-08-15 | 2026-03-04 |
| Evaluating the Impact of Financial Navigation on Financial Catastrophe and Distress for Cancer Care Financial Navigation Program - Breast Neoplasm, Prostate Neoplasm | Not applicable | Recruiting | Northwestern University | 200 | 2024-07-15 | 2024-10-08 |
| Cryoablation vs Lumpectomy in T1 Breast Cancers Endocare SlimLine Cryoprobe, Lumpectomy - Breast Cancer, Breast Neoplasm | Not applicable | Recruiting | Washington University School of Medicine | 120 | 2024-04-03 | 2026-02-27 |
| Study of Anxiety After a Session of Energy Resonance by Cutaneous Stimulation Energy Resonance by Cutaneous Stimulation - Breast Neoplasm | Not applicable | Completed | Centre Henri Becquerel | 57 | 2024-01-08 | 2026-01-02 |
| Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer. SV-BR-1-GM, Cyclophosphamide, Interferon infiltration of the inoculation site - Breast Cancer, Metastatic Breast Cancer | Phase 3 | Recruiting | BriaCell Therapeutics Corporation | 404 | 2023-12-05 | 2026-09-02 |
| HOBBIT 3: Mental Exercises and Temporal Alteration Mental Exercises and Temporal Alteration - Breast Neoplasm, Radiotherapy | Not applicable | Completed | University Hospital, Ghent | 36 | 2023-11-27 | 2026-02-13 |
| A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer MBQ-167 - Breast Cancer, Breast Neoplasm | Phase 1 | Recruiting | MBQ Pharma | 48 | 2023-11-09 | 2026-08-31 |
| The Study of Trilaciclib Combined With Chemotherapy On The Neoadjuvant Therapy of TNBC Trilaciclib plus chemotherapy, Chemotherapy - Breast Neoplasm | Phase 2 | Not yet recruiting | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 150 | 2023-07-30 | 2023-07-24 |
| A Study of Ado-trastuzumab Emtansine (T-DM1)-Induced Peripheral Neuropathy in HER2-positive Breast Cancer Patients Breast Neoplasm | Active not recruiting | Mayo Clinic | 36 | 2023-06-12 | 2025-11-20 | |
| Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study Palbociclib, Ribociclib, Abemaciclib - Breast Adenocarcinoma, Breast Cancer Stage IV | Recruiting | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 3500 | 2023-05-01 | 2025-02-03 | |
| Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer Paclitaxel, Carboplatin, Trastuzumab - Breast Cancer, Breast Neoplasm | Phase 2 | Recruiting | Baylor Breast Care Center | 185 | 2023-04-18 | 2025-02-27 |
Showing 20 of 169. Sign in to see all of them.
Breast Neoplasms (169) · Neoplasms (14) · Neoplasm Metastasis (12) · Triple Negative Breast Neoplasms (8) · Colorectal Neoplasms (6) · Lymphedema (6) · Ovarian Neoplasms (6) · Prostatic Neoplasms (6) · Head and Neck Neoplasms (5) · Motor Activity (5) · Pancreatic Neoplasms (5) · Melanoma (4) · Anxiety Disorders (3) · Brain Neoplasms (3) · Breast Diseases (3)
Neoplasms by Site (169) · Skin and Connective Tissue Diseases (169) · Skin Diseases (168) · Breast Diseases (166) · Neoplasms (155) · Pathological Conditions, Signs and Symptoms (24) · Pathologic Processes (16) · Urogenital Diseases (15) · Neoplasms by Histologic Type (14) · Female Urogenital Diseases (13) · Female Urogenital Diseases and Pregnancy Complications (13) · Neoplastic Processes (13) · Urogenital Neoplasms (13) · Digestive System Diseases (12) · Genital Diseases (11)
Cyclophosphamide (12) · Fulvestrant (8) · Paclitaxel (6) · Trastuzumab (6) · Carboplatin (5) · Exercise (5) · Letrozole (5) · Docetaxel (4) · Doxorubicin (4) · Mastectomy, Segmental (4) · Standard of Care (4) · liposomal doxorubicin (4) · Anastrozole (3) · Capecitabine (3) · Epirubicin (3)
Merck Sharp & Dohme LLC (7) · National Cancer Institute (NCI) (7) · Mayo Clinic (5) · University of Pennsylvania (4) · BriaCell Therapeutics Corporation (3) · Columbia University (3) · G1 Therapeutics, Inc. (3) · Universitaire Ziekenhuizen KU Leuven (3) · University of Washington (3) · Fudan University (2) · Instituto Nacional de Cancer, Brazil (2) · Instituto Nacional de Cancerologia de Mexico (2) · M.D. Anderson Cancer Center (2) · MedSIR (2) · OHSU Knight Cancer Institute (2)
United States (69) · South Korea (12) · Belgium (11) · Canada (9) · Spain (9) · China (8) · Germany (8) · France (7) · Brazil (6) · Italy (6) · Sweden (6) · United Kingdom (6) · Netherlands (5) · Austria (4) · Mexico (4)
David Mankoff, MD, PhD (2) · George E Peoples, MD, FACS (2) · Georgiana K. Ellis, M.D. (2) · Kerri M Winters, PhD (2) · A. Elise van Leeuwen-Stok, PhD (1) · Abida K. Sattar, MD (1) · Alexandre Biasi Cavalcante, PhD (1) · An De Groef, PhD (1) · Ana Maria Lopez, MD (1) · Andrew Chang, MD (1) · Andrew D Seidman, MD (1) · Andrew Tutt (1)
PMID 29141853, PMID 11226762, PMID 12686700, PMID 12697943, PMID 1352024, PMID 15139073, PMID 15501952, PMID 16766588, PMID 17187507, PMID 17530482, PMID 18525044, PMID 19037667, PMID 19380449, PMID 19767314, PMID 19858391, PMID 20012355, PMID 20697802, PMID 20972805, PMID 21424279, PMID 21533811, PMID 21746696, PMID 22056854, PMID 22193780, PMID 22248721, PMID 22488022, PMID 22939099, PMID 22996743, PMID 23225299, PMID 23358260, PMID 23542954, PMID 24317968, PMID 24354107, PMID 24761161, PMID 25012726, PMID 25034821, PMID 25106522, PMID 25376971, PMID 25480319, PMID 25587516, PMID 25769963, PMID 26497721, PMID 26588217, PMID 26769776, PMID 27900579, PMID 28274211, PMID 29467138, PMID 30656609, PMID 30689105, PMID 30759059, PMID 30949435
2016 (2), 2014 (1), 2017 (1), 2018 (1), 2023 (1), P01CA190193 (1), P30CA016672 (1), P30CA124435 (1), R01AT006515 (1), R01CA177995 (1), R01CA226078 (1), R01CA239548 (1), R01CA255480 (1), UG1CA189823 (1)